D. Dobryanskyy
YOU?
Author Swipe
FEATURES OF RESPIRATORY SUPPORT IN INFANTS WITH SEVERE BRONCHOPULMONARY DYSPLASIA Open
Improved survival rates for extremely preterm infants have not reduced the incidence of bronchopulmonary dysplasia (BPD), which is still diagnosed in a significant proportion of these infants. Despite the availability of several effective …
LATE PREMATURE INFANTS – AN UNDERESTIMATED HIGH-RISK GROUP IN NEONATOLOGY Open
The risks associated with late preterm births have historically been significantly underestimated. Late preterm infants (LPIs) are born with structurally and functionally immature lungs, characterized by insufficient surfactant production,…
View article: Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) Taskforce
Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) Taskforce Open
Background Long-acting monoclonal antibodies (LAmAbs) could dramatically reduce the respiratory syncytial virus (RSV) disease burden in children if implemented using clear, evidence-based recommendations. Methods The ARMADA Taskforce—an in…
Risk factors of bronchopulmonary dysplasia depending on the severity of the disease in very preterm infants Open
Duration of respiratory support is the main risk factor that determines the development of moderate/severe BPD in the modern population of very preterm infants. Maternal hypertension and genitourinary infections may influence the severity …
LONG-TERM RESPIRATORY OUTCOMES OF PRETERM BIRTHS Open
Both children and adults who were born prematurely are more likely to suffer from respiratory diseases throughout their lives, which can lead to a decline in lung structure and function over time. Current evidence indicates that there may …
Clinical and laboratory features of COVID-19 in newborns. Analysis of a severe clinical case Open
Background. Since the onset of the coronavirus disease 2019 (COVID-19) epidemic until January 1, 2024, more than 5.5 million confirmed cases of COVID-19 have been detected in Ukraine according to official data, approximately 6 % of them am…
BREAST MILK FORTIFICATION FOR PRETERM INFANTS Open
Mother’s own milk is the optimal food for infants. It is characterized not only by a unique balanced composition of nutrients, but also by essential biological properties, which is especially important for preterm infants. If there is no m…
RISK FACTORS ASSOCIATED WITH PROLONGED MECHANICAL VENTILATION IN VERY LOW BIRTH WEIGHT INFANTS Open
Introduction. Mechanical ventilation (MV) remains a life-saving intervention for the sickest very low birth weight (VLBW) neonates. Despite the widespread use of non-invasive respiratory support, many VLBW neonates require some duration of…
Probiotics, gut microbiota, and diseases associated with the immaturity of the digestive tract in very preterm infants Open
Interruption of the formation of gut microbiota in preterm infants increases the probability of necrotizing enterocolitis (NEC) and late-onset neonatal sepsis (LOS). The use of probiotics can reduce the corresponding risk. Purpose - to eva…
MORPHOLOGICAL EVOLUTION AND DIAGNOSIS OF BRONCHOPULMONARY DYSPLASIA IN VERY PRETERM INFANTS Open
Bronchopulmonary dysplasia (BPD) remains one of the most common and severe diseases in very preterm infants, which can cause death. Since the first description of BPD in 1967, not only understanding of the disease’s nature, its definition,…
Fecal calprotectin, lactoferrin and morbidity associated with immature digestive tract in preterm infants Open
Introduction. Excessive intestinal inflammation in preterm infants is one of the key factors in the development of necrotizing enterocolitis (NEC), early- (EOS) and late-onset neonatal sepsis (LOS). Purpose - to evaluate the connection bet…
STANDARDS OF MEDICAL CARE “INVASIVE CANDIDIASIS IN NEWBORNS” Open
Candida infection (candidiasis) is an important clinical problem in newborns who need treatment in modern intensive care units. Organ and/or systemic infections caused by these fungi are called invasive candidiasis (IC). Newborns are espec…
PULMONARY HYPERTENSION IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA: CAUSES, DIAGNOSIS, TREATMENT Open
Bronchopulmonary dysplasia (BPD) is a leading chronic pathology of premature infants, which changes the structure of the lungs and disrupts the development of pulmonary vessels. The most important cardiovascular complication of BPD is the …
NEW APPROACHES TO THE DEFINITION AND CLASSIFICATION OF BRONCHOPULMONARY DYSPLASIA IN PRETERM INFANTS Open
Bronchopulmonary dysplasia (BPD) remains a pressing problem of modern neonatology and pediatrics. Since this disease is chronic and often results in negative long-term consequences, the search for the optimal definition of BPD that would b…
Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial Open
Background Patent ductus arteriosus (PDA) is a common complication in very preterm infants. It is known that there is an association between PDA and development of bronchopulmonary dysplasia (BPD) or death before the postmenstrual age (PMA…
OPPORTUNITIES AND PERSPECTIVES OF IMMUNE NUTRITION IN PRETERM INFANTS Open
While mortality associated withrespiratory distress syndrome in premature infants hasbeen reduced, other morbidities associated with pretermbirth, including necrotizing enterocolitis (NEC) and sepsis,are becoming more relevant. Although th…
Predictive value of serum NT-proBNP concentrations for assessment hemodynamically significant patent ductus arteriosus in very preterm infants Open
Hemodynamically significant patent ductus arteriosus (PDA) is a common complication in very preterm infants born at less than 32 weeks of gestation. At the same time, currently, there are no uniform criteria to identify the actual hemodyna…
Predictive value of blood N-terminal pro-brain natriuretic peptide concentrations for early patent ductus closure in very preterm infants Open
Serum NT-proBNP concentrations on the second day of life could reliably predict early PDA closure in treated but not in expectantly managed very preterm infants.
EXOGENOUS SURFACTANTS OF NATURAL ORIGIN IN THE TREATMENT OF RESPIRATORY DISTRESS SYNDROME - COMPARATIVE COMPOSITION, BIOPHYSICAL PROPERTIES AND CLINICAL EFFECTIVENESS Open
Respiratory distress syndrome (RDS) remains an important cause of morbidity and mortality in premature infants in Ukraine and around the world. Since the determination of surfactant deficiency as the main cause of this disease, significant…
CARE FOR NEWBORNS FROM MOTHERS WITH SUSPECTED OR CONFIRMED COVID-19 Open
Від початку спалаху COVID-19 численні публікації висвітлювали особливості цієї інфекції у дорослих,проте епідеміологічні і клінічнідані щодо новонароджених залишаються суперечливими і фрагментарними. Водночас, зі значним і швидким збільшен…
EARLY USE OF CONTINUOUS POSITIVE AIR WAY PRESSURE FOR PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS SYNDROME IN PRETERM INFANTS Open
Дихальна підтримка (ДП) займає провідне місце у забезпеченні постнатальної респіраторної адаптації і лікуванні недоношених новонароджених. На сьогодні немає сумнівів щодо клінічних переваг раннього застосування неінвазивних методів ДП порі…
MANAGEMENT OF PATENT DUCTUS ARTERIOSUS IN VERY PRETERM NEWBORNS: CURRENT CONTROVERSIES AND RECOMMENDATIONS Open
Згідно з даними численних досліджень персистенція відкритої артеріальної протоки (ВАП) асоціюється з підвищеними захворюваністю та смертністю значно недоношених немовлят. Профілактичне призначення ліків, які запобігають виникненню або змен…
MANAGEMENT OF PATENT DUCTUS ARTERIOSUS IN VERY PRETERM NEWBORNS: DO WE HAVE A PREFERENCE? Open
Introduction. Patent ductus arteriosus (PDA) is a common problem in preterm infants, which can cause complications and worsen the results of treatment. However, there is no unambiguous approach to the management of PDA. Objective. The aim …
SURFACTANT THERAPY AND BRONCHOPULMONARY DYSPLASIA DEVELOPMENT IN VERY PRETERM INFANTS Open
In a prospective cohort study the association between surfactant therapy and development (severity) of bronchopulmonary dysplasia (BPD) in very preterm infants required mechanical ventilation after birth was studied taking into account inf…
Long-term outcomes of bronchopulmonary dysplasia in preterm infants Open
Бронхолегенева дисплазія (БЛД) залишається важливою причиною захворюваності і смертності глибоко недоношених немовлят, істотно впливаючи на кінцеві результати їх виходжування.Це захворювання асоціюється з підвищеною захворюваністю і поруше…
TREATMENT OF RESPIRATORY DISTRESS-SYNDROME IN PRETERM NEWBORNS WITH THE USE OF EXOGENOUS SURFACTANT (PORACTANT ALFA): CLINLCAL GUIDLINES Open
Респіраторний дистрес-синдром (РДС) – це гостре захворювання легень, яке виникає переважно в недоношених новонароджених внаслідок дефіциту легеневого сурфактанту і незрілості дихальної системи. Його симптоми з’являються невдовзі після наро…
OLIGOSACCHARIDES IN HUMAN MILK AND IN MILK FORMULAS FOR PRETERM INFANTS – VALUE FOR PRETERM INFANTS Open
Краще довгострокове виживання значно недоношених немовлят залежить від оптимізації методів їх нутритивного забезпечення. На сьогодні загальновизнано, що грудне молоко (ГМ) матері є оптимальним продуктом ентерального харчування для цієї над…
Effectiveness and safety of pneumothorax management in newborns without chest-tube insertion Open
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Menshykova A, Dobryanskyy D. Effectiveness and safety of pneumothorax management in newborns without chest-tube insertion. Pediatria Polska - Polish Journal …